Report - Neue Arzneimittel 2013/2014 - akdae.de · Evidence, Hoffman-La Roche, IMS Health, Novartis Pharma, PMRA Consulting, PriceSpective, TEVA-ratiopharm, Kantar Health . 120. Kongress der

Select PornographicDefamatoryIllegal/UnlawfulSpamOther Terms Of Service ViolationFile a copyright complaint

Please pass captcha verification before submit form